4.4 Article

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction

Journal

BMC NEUROLOGY
Volume 21, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12883-021-02301-w

Keywords

Transient ischemic attack; Cerebral infarction; ALDOA; FH; Antibody biomarker

Funding

  1. Japan Agency for Medical Research and Development (AMED) of Japan
  2. JSPS KAKENHI [20K17953, 19K09451, 17K19810, 17K16626]
  3. Natural Science Foundation of Guangdong Province, China [2018A0303131003]
  4. Science and Technology Program of Guangzhou, China [201707010449]
  5. Toka-Donghua Educational and Cultural Exchange Foundation
  6. Setsuro Fujii Memorial of Medical Sciences
  7. Osaka Foundation for Promotion of Fundamental Medical Research
  8. National Cancer Center Research and Development Fund
  9. Ministry of Health, Labour and Welfare of Japan
  10. Grants-in-Aid for Scientific Research [19K09451, 20K17953, 17K16626, 17K19810] Funding Source: KAKEN

Ask authors/readers for more resources

The study identified ALDOA and FH as potential biomarkers for predicting atherosclerotic TIA and aCI, as levels of ALDOA-Ab and FH-Ab in serum were found to be associated with the risk of TIA and aCI. The antibody levels were also correlated with hypertension, coronary heart disease, habitual smoking, and maximum intima-media thickness.
Background Ischemic stroke, including transient ischemic attack (TIA) and acute-phase cerebral infarction (aCI), is a serious health problem in the aging society. Thus, this study aimed to identify TIA and aCI biomarkers. Methods In 19 patients with TIA, candidate antigens recognized by serum IgG autoantibodies were screened using a human aortic endothelial cell cDNA library. Through amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA), serum antibody levels against the candidate antigens were examined in healthy donor (HD), TIA, and aCI cohorts (n = 285, 92, and 529). The plasma antibody levels in the Japan Public Health Center-based Prospective Cohort Study (1991-1993) were also examined. Results The candidate antigens were aldolase A (ALDOA) and fumarate hydratase (FH). In AlphaLISA, patients with TIA or aCI had higher anti-ALDOA antibody (ALDOA-Ab) and anti-FH antibody (FH-Ab) levels than the HDs (P < 0.05). In a multivariate logistic regression analysis, the ALDOA-Ab (odds ratio [OR]: 2.46, P = 0.0050) and FH-Ab (OR: 2.49, P = 0.0037) levels were independent predictors of TIA. According to the case-control study, the ALDOA-Ab (OR: 2.50, P < 0.01) and FH-Ab (OR: 2.60, P < 0.01) levels were associated with aCI risk. In a correlation analysis, both ALDOA-Abs and FH-Abs were well associated with hypertension, coronary heart disease, and habitual smoking. These antibody levels also correlated well with maximum intima-media thickness, which reflects atherosclerotic stenosis. Conclusions ALDOA-Abs and FH-Abs can be novel potential biomarkers for predicting atherosclerotic TIA and aCI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available